Ketamine for Treatment-Resistant Bipolar Disorder

NCT05004896 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Disorder
Bipolar Depression
Bipolar I Disorder
Bipolar II Disorder

Interventions

DRUG: Ketamine Hydrochloride
DRUG: Midazolam Hydrochloride

Sponsor

Joshua Rosenblat